FDG-PET-positive ovarian thecoma with GLUT5 expression: Five cases
FDG-PET-positive ovarian thecoma with GLUT5 expression: Five cases
复制标题
DOI:
10.1111/jog.13243
复制
发表时间:
2017-03-01
影响因子:
1.6
通讯作者:
Fujiwara, Hiroshi
中科院分区:
文献类型:
--
作者:
Bono, Yukiko;Mizumoto, Yasunari;Fujiwara, Hiroshi
Positron emission tomography (PET) with fluorodeoxyglucose F18 (F-18-FDG) is useful for detecting malignancies, but benign lesions occasionally have false-positive F-18-FDG uptake. Here, we report the cases of five postmenopausal women with solid ovarian tumors suspected to be ovarian cancer on magnetic resonance imaging and F-18-FDG uptake. Mean age of the five patients was 57 years (range, 53-65 years). Average early standardized uptake value (SUV) of F-18-FDG was 5.76 (range, 2.2-12.0) and delayed SUV was 6.56 (range, 2.4-13.8). In all five patients, frozen section diagnosis at surgery was thecoma, and bilateral salpingo-oophorectomy was performed. On immunohistochemistry, immunoreactive glucose transporter 5 (GLUT5) expression was detected in thecoma tissues. This case shows that thecoma sometimes has positive F-18-FDG uptake on positron emission tomography-computed tomography (PET-CT), indicating the need for caution regarding false-positive PET-CT in patients with benign solid ovarian tumor.